Flanagan, Kevin C.
Earls, Jon
Schillebeeckx, Ian
Hiken, Jeffrey
Wellinghoff, Rachel L.
LaFranzo, Natalie A.
Bradley, Zachary S.
Babbitt, Joey
Westra, William H.
Hsu, Raymond
Nadauld, Lincoln
Mcleod, Howard
Firth, Sean D.
Sharp, Brittany
Fuller, Josh
Vavinskaya, Vera
Sutton, Leisa
Deichaite, Ida
Bailey, Samuel D.
Sandulache, Vlad C.
Rendo, Matthew J.
Macdonald, Orlan K.
Welaya, Karim
Wade, James L. III
Pippas, Andrew W.
Slim, Jennifer
Bank, Bruce
Saccaro, Steven J.
Sui, Xingwei
Akhtar, Adil
Balaraman, Savitha
Kossman, Steven E.
Sonnier, Scott A.
Shenkenberg, Todd D.
Alexander, Warren L.
Price, Katherine A.
Bane, Charles L.
Ley, Jessica
Messina, David N.
Glasscock, Jarret I.
Cohen, Ezra E. W.
Adkins, Douglas R.
Duncavage, Eric J.
Article History
Received: 26 June 2023
Accepted: 23 July 2023
First Online: 8 August 2023
Declarations
:
: KCF, JE, IS, JH, RLW, NAL, ZSB, JB, DNM, JIG, and EJD are employed, have stock interests, and/or a financial relationship with Cofactor Genomics, Inc., maker of the OncoPrism test.
: The study protocol was approved by WCG IRB. Independent data monitoring was conducted by the study clinical research organization Curebase, Inc (San Francisco, CA).
: All patients provided signed, informed consent to participate, or consent was waived for deceased patients according to study protocol.
: Not applicable.